The purpose of this study is to determine if an investigational treatment can address the underlying cause of Graves' disease, and potentially normalize thyroid hormone levels.

Do you have incurable, metastatic head and neck squamous cell carcinoma ? If so, you may be able to take part in a study to see if a new drug called Cisplatin is effective.

Help us improve resources for patients with rheumatic conditions! This is a brief, anonymous survey aimed to gather information about what additional resources you'd like to learn about from your rheumatology care team. Learning about your interest and priorities will inform future development of programs, resources, and tools to promote health.

This study is exploring whether the new drug combo of TNG462 + RMC‑6236/9805 can be safely given to patients with tough pancreatic or lung cancers that have specific genetic markers, and if it shows promising early signs of fighting the cancer.

Do you have a cough that hasn't gone away for more than 8 weeks? Does your cough bother you or make it hard to do normal activities? If your cough continues and you feel it is not well managed, you may be able to participate in a research study to find out how chronic cough is treated and how it affects daily life and other health conditions. Compensation provided.

This project aims to test the cognitive mechanisms involved in language production by healthy adults.

Are you battling triple-negative breast cancer? If your cancer has come back or spread, and you haven't started treatment yet, you might qualify for a clinical trial testing a new medication. Discover more about this opportunity to find a potentially better treatment option.

This study is being done to see if an investigational medication works better than a placebo (dummy medicine) for weight loss.

Do you have plaque type psoriasis? You may be able to participate in a research study to find out if an investigational medication (zasocitinib) works better than an already FDA approved medication for psoriasis (deucravacitinib).

Have you diagnosed with lymph node positive early breast cancer, have received surgery, and have not received any systemic or radiation treatment prior to surgery? If so, you may be able to take part in this clinical trial which seeks to improve the treatment of early-stage breast cancer by examining ctDNA, a biomarker found in the blood that may indicate the presence of disease. This study aims to determine if ctDNA can help doctors personalize therapies leading to more effective treatment plans.